(Q40642297)

22 September 2017

Disturbed secretion of mutant adiponectin associated with the metabolic syndrome (English)

1 reference

22 September 2017

1 reference

16

Tohru Funahashi

1 reference

22 September 2017

17

Yuji Matsuzawa

1 reference

22 September 2017

Ken Kishida

1

1 reference

22 September 2017

Hiroyuki Nagaretani

2

1 reference

22 September 2017

Hidehiko Kondo

3

1 reference

22 September 2017

Hideki Kobayashi

4

1 reference

22 September 2017

Sachiyo Tanaka

5

1 reference

22 September 2017

Norikazu Maeda

6

1 reference

22 September 2017

Azumi Nagasawa

7

1 reference

22 September 2017

Toshiyuki Hibuse

8

1 reference

22 September 2017

Koji Ohashi

9

1 reference

22 September 2017

Masahiro Kumada

10

1 reference

22 September 2017

Hitoshi Nishizawa

11

1 reference

22 September 2017

Yoshihisa Okamoto

12

1 reference

22 September 2017

Noriyuki Ouchi

13

1 reference

22 September 2017

Kazuhisa Maeda

14

1 reference

22 September 2017

Shinji Kihara

15

1 reference

22 September 2017

language of work or name

1 reference

1 June 2003

1 reference

Biochemical and Biophysical Research Communications

22 September 2017

1 reference

22 September 2017

306

1 reference

22 September 2017

1

1 reference

22 September 2017

286-292

1 reference

Pathophysiology and pathogenesis of visceral fat obesity

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

The role of TNFalpha and TNF receptors in obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

AdipoQ is a novel adipose-specific gene dysregulated in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

A novel serum protein similar to C1q, produced exclusively in adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Genomic structure and mutations in adipose-specific gene, adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

C1q: structure, function, and receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Adiponectin and development of type 2 diabetes in the Pima Indian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900940-9

10.1016/S0006-291X(03)00940-9

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference